BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glennon EKK, Dankwa S, Smith JD, Kaushansky A. Opportunities for Host-targeted Therapies for Malaria. Trends Parasitol 2018;34:843-60. [PMID: 30122551 DOI: 10.1016/j.pt.2018.07.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Zuniga M, Gomes C, Chen Z, Martinez C, Devlin JC, Loke P, Rodriguez A. Plasmodium falciparum and TNF-α Differentially Regulate Inflammatory and Barrier Integrity Pathways in Human Brain Endothelial Cells. mBio 2022;:e0174622. [PMID: 36036514 DOI: 10.1128/mbio.01746-22] [Reference Citation Analysis]
2 Paone S, Olivieri A. Role of Host Small GTPases in Apicomplexan Parasite Infection. Microorganisms 2022;10:1370. [DOI: 10.3390/microorganisms10071370] [Reference Citation Analysis]
3 Chaudhary A, Kataria P, Surela N, Das J. Pathophysiology of Cerebral Malaria: Implications of MSCs as A Regenerative Medicinal Tool. Bioengineering (Basel) 2022;9:263. [PMID: 35735506 DOI: 10.3390/bioengineering9060263] [Reference Citation Analysis]
4 Boulet C, Siddiqui G, Gaynor TL, Doerig C, Creek DJ, Carvalho TG. Red Blood Cell BCL-xL Is Required for Plasmodium falciparum Survival: Insights into Host-Directed Malaria Therapies. Microorganisms 2022;10:824. [PMID: 35456874 DOI: 10.3390/microorganisms10040824] [Reference Citation Analysis]
5 Baindara P, Agrawal S, Franco OL. Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs. Expert Review of Anti-infective Therapy. [DOI: 10.1080/14787210.2022.2044794] [Reference Citation Analysis]
6 Glennon EKK, Tongogara T, Primavera VI, Reeder SM, Wei L, Kaushansky A. Elucidating Spatially-Resolved Changes in Host Signaling During Plasmodium Liver-Stage Infection. Front Cell Infect Microbiol 2022;11:804186. [DOI: 10.3389/fcimb.2021.804186] [Reference Citation Analysis]
7 Wei W, Cheng W, Dai W, Lu F, Cheng Y, Jiang T, Ren Z, Xie Y, Xu J, Zhao Q, Yu X, Yin Y, Li J, Dong H. A Nanodrug Coated with Membrane from Brain Microvascular Endothelial Cells Protects against Experimental Cerebral Malaria. Nano Lett 2021. [PMID: 34967631 DOI: 10.1021/acs.nanolett.1c03514] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Xu X, Zhang QY, Chu XY, Quan Y, Lv BM, Zhang HY. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge. Viruses 2021;13:2117. [PMID: 34834924 DOI: 10.3390/v13112117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wei L, Adderley J, Leroy D, Drewry DH, Wilson DW, Kaushansky A, Doerig C. Host-directed therapy, an untapped opportunity for antimalarial intervention. Cell Rep Med 2021;2:100423. [PMID: 34693368 DOI: 10.1016/j.xcrm.2021.100423] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Vijayan K, Wei L, Glennon EKK, Mattocks C, Bourgeois N, Staker B, Kaushansky A. Host-targeted Interventions as an Exciting Opportunity to Combat Malaria. Chem Rev 2021;121:10452-68. [PMID: 34197083 DOI: 10.1021/acs.chemrev.1c00062] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Dankwa S, Dols MM, Wei L, Glennon EKK, Kain HS, Kaushansky A, Smith JD. Exploiting polypharmacology to dissect host kinases and kinase inhibitors that modulate endothelial barrier integrity. Cell Chem Biol 2021:S2451-9456(21)00303-2. [PMID: 34216546 DOI: 10.1016/j.chembiol.2021.06.004] [Reference Citation Analysis]
12 Simão-Gurge RM, Thakre N, Strickland J, Isoe J, Delacruz LR, Torrevillas BK, Rodriguez AM, Riehle MA, Luckhart S. Activation of Anopheles stephensi Pantothenate Kinase and Coenzyme A Biosynthesis Reduces Infection with Diverse Plasmodium Species in the Mosquito Host. Biomolecules 2021;11:807. [PMID: 34072373 DOI: 10.3390/biom11060807] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Boulet C, Gaynor TL, Carvalho TG. Eryptosis and Malaria: New Experimental Guidelines and Re-Evaluation of the Antimalarial Potential of Eryptosis Inducers. Front Cell Infect Microbiol 2021;11:630812. [PMID: 33777843 DOI: 10.3389/fcimb.2021.630812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Paone S, D'Alessandro S, Parapini S, Celani F, Tirelli V, Pourshaban M, Olivieri A. Characterization of the erythrocyte GTPase Rac1 in relation to Plasmodium falciparum invasion. Sci Rep 2020;10:22054. [PMID: 33328606 DOI: 10.1038/s41598-020-79052-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Hentzschel F, Obrova K, Marti M. No evidence for Ago2 translocation from the host erythrocyte into the Plasmodium parasite. Wellcome Open Res 2020;5:92. [PMID: 33501380 DOI: 10.12688/wellcomeopenres.15852.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zou Y, Tuo F, Zhang Z, Guo J, Yuan Y, Zhang H, Xu Z, Pan Z, Tang Y, Deng C, Julie N, Wu W, Guo W, Li C, Huang X, Xu Q, Song J, Wang Q. Safety and Efficacy of Adjunctive Therapy With Artesunate in the Treatment of Severe Malaria: A Systematic Review and Meta-Analysis. Front Pharmacol 2020;11:596697. [PMID: 33343367 DOI: 10.3389/fphar.2020.596697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ménard D, Houzé S, Papon N. RIFINing Plasmodium-NK Cell Interaction. Trends Parasitol 2020;36:802-4. [PMID: 32800428 DOI: 10.1016/j.pt.2020.07.017] [Reference Citation Analysis]
18 Erice C, Kain KC. New insights into microvascular injury to inform enhanced diagnostics and therapeutics for severe malaria. Virulence 2019;10:1034-46. [PMID: 31775570 DOI: 10.1080/21505594.2019.1696621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
19 Varo R, Erice C, Johnson S, Bassat Q, Kain KC. Clinical trials to assess adjuvant therapeutics for severe malaria. Malar J 2020;19:268. [PMID: 32709257 DOI: 10.1186/s12936-020-03340-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, Jesus Andreoli Pinto T, Silva MW, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review. Drug Dev Res 2020;81:837-58. [DOI: 10.1002/ddr.21704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
21 Balasubramanian L, Zuzarte-Luís V, Syed T, Mullick D, Deb S, Ranga-Prasad H, Meissner J, Almeida A, Furstenhaupt T, Siddiqi K, Prudêncio M, Rodrigues CMP, Mota M, Sundaramurthy V. Association of Plasmodium berghei With the Apical Domain of Hepatocytes Is Necessary for the Parasite's Liver Stage Development. Front Cell Infect Microbiol 2019;9:451. [PMID: 32010639 DOI: 10.3389/fcimb.2019.00451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Vera IM, Grilo Ruivo MT, Lemos Rocha LF, Marques S, Bhatia SN, Mota MM, Mancio-Silva L. Targeting liver stage malaria with metformin. JCI Insight 2019;4:127441. [PMID: 31852843 DOI: 10.1172/jci.insight.127441] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
23 Mellin R, Boddey JA. Organoids for Liver Stage Malaria Research. Trends Parasitol 2020;36:158-69. [PMID: 31848118 DOI: 10.1016/j.pt.2019.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
24 Matralis AN, Malik A, Penzo M, Moreno I, Almela MJ, Camino I, Crespo B, Saadeddin A, Ghidelli-Disse S, Rueda L, Calderon F, Osborne SA, Drewes G, Böesche M, Fernández-Álvaro E, Martin Hernando JI, Baker DA. Development of Chemical Entities Endowed with Potent Fast-Killing Properties against Plasmodium falciparum Malaria Parasites. J Med Chem 2019;62:9217-35. [PMID: 31566384 DOI: 10.1021/acs.jmedchem.9b01099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
25 Peter S, Aderibigbe BA. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity. Molecules 2019;24:E3604. [PMID: 31591298 DOI: 10.3390/molecules24193604] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 20.3] [Reference Citation Analysis]
26 Asquith CRM, Fleck N, Torrice CD, Crona DJ, Grundner C, Zuercher WJ. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines. Bioorg Med Chem Lett 2019;29:2695-9. [PMID: 31378571 DOI: 10.1016/j.bmcl.2019.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
27 Raphemot R, Toro-Moreno M, Lu KY, Posfai D, Derbyshire ER. Discovery of Druggable Host Factors Critical to Plasmodium Liver-Stage Infection. Cell Chem Biol 2019;26:1253-1262.e5. [PMID: 31257182 DOI: 10.1016/j.chembiol.2019.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
28 Nishanth G, Schlüter D. Blood-Brain Barrier in Cerebral Malaria: Pathogenesis and Therapeutic Intervention. Trends Parasitol 2019;35:516-28. [PMID: 31147271 DOI: 10.1016/j.pt.2019.04.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 8.7] [Reference Citation Analysis]
29 Pais TF, Penha-Gonçalves C. Brain Endothelium: The "Innate Immunity Response Hypothesis" in Cerebral Malaria Pathogenesis. Front Immunol 2018;9:3100. [PMID: 30761156 DOI: 10.3389/fimmu.2018.03100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
30 Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, Navia MA, Schiffer CA. A call to arms: Unifying the fight against resistance. Sci Signal 2018;11:eaav0442. [PMID: 30352947 DOI: 10.1126/scisignal.aav0442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 [DOI: 10.1101/2020.08.31.275867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]